Priming scientists for successful media ...(of topics including safely speaking on b...)
Navigation Links
Priming scientists for successful media interviews
Date:2/13/2008
of topics, including safely speaking on behalf of an organization, avoiding trouble when discussing socially or politically controversial topics, and reflections on first interviews.
The Primer also provides worksheets to assist readers with interview preparation: building a message framework with talking points and transition phrases, developing analogies, and using illustrative props or images. It includes pages for readers to organize contact information of journalists with whom they have worked directly and those who have reported on stories related to their own research to keep as potential contacts for future story pitches.
"Communicating Science: A Primer for Working with the Media" is available now at www.aibs.org/bookstore/
The table of contents and cover image are also available at www.aibs.org/bookstore/
'/>"/>
| Contact: Holly Menninger hmenninger@aibs.org 202-628-1500 x229 American Institute of Biological Sciences Source:Eurekalert |
Related biology news :
1. Scientists expand understanding of how river carbon impacts the Arctic Ocean
2. Fishermen and UCSB scientists explore ways to improve management of California spiny lobsters
3. Scientists rebuild ancient proteins to reveal primordial Earths temperature
4. Rice scientists make breakthrough in single-molecule sensing
5. Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design
6. Scientists obtain core samples from subsea fault system off Japan
7. Scientists discover new species of giant elephant-shrew
8. Scientists outline novel approach to ecosystem management
9. Scientists achieve major genetics breakthrough
10. In nature -- and maybe the corner office -- scientists find that generalists can thrive
11. Using DNA, scientists hunt for the roots of the modern potato
Post Your Comments:
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Scientists discover gene module underlying atherosclerosis development 2Medicinal products susceptible to dose dumping should be fully tested 58148 157 college presidents declare support for public access to publicly funded research in the US 10057 157 college presidents declare support for public access to publicly funded research in the US 10057 257 college presidents declare support for public access to publicly funded research in the US 10057 3Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics 28TCT 29 Meeting 58143 1Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics 28TCT 29 Meeting 58143 2
Other Biology News:Climate change could be impetus for wars, other conflicts, expert says 2Climate change could be impetus for wars, other conflicts, expert says 3Climate change could be impetus for wars, other conflicts, expert says 4Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage 2Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage 3Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage 4Tahitian vanilla originated in Maya forests, says UC Riverside botanist 2Tahitian vanilla originated in Maya forests, says UC Riverside botanist 3
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
[0] VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291[0] Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock[0] Martek to Announce Fourth Quarter and Fiscal Year 2009 Results[0] Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective
Other Biology Technology:NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 2NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 3NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 4NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 5Children's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership Program 2Bedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers 2
NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza StrainsChildren's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership ProgramBedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |